Effect of calcitriol and age on recovery from hypocalcemia in hemodialysis patients.
暂无分享,去创建一个
[1] R. Lindsay,et al. Resistance to Bone Resorbing Effects of PTH in Black Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] E. Lonergan,et al. Aging alters calcium regulation of serum concentration of parathyroid hormone in healthy men. , 1997, The American journal of physiology.
[3] E. Ritz,et al. Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium. , 1996, The Journal of clinical endocrinology and metabolism.
[4] E. Aguilera-Tejero,et al. Hysteresis of the PTH‐calcium curve during hypocalcemia in the dog: Effect of the rate and linearity of calcium decrease and sequential episodes of hypocalcemia , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] A. Felsenfeld,et al. The set point of calcium--another view. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] E. Lonergan,et al. Aging and renal responsiveness to parathyroid hormone in healthy men. , 1996, The Journal of clinical endocrinology and metabolism.
[7] M. Burritt,et al. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. , 1996, The Journal of clinical endocrinology and metabolism.
[8] J. Bover,et al. The set point of calcium and the reduction of parathyroid hormone in hemodialysis patients. , 1996, Kidney international.
[9] H. Malluche,et al. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] J. Souberbielle,et al. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] J. Bover,et al. Development of secondary hyperparathyroidism and bone disease in diabetic rats with renal failure. , 1995, Kidney international.
[12] D Hernández,et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. , 1995, Kidney international.
[13] J. Bover,et al. Studies in a hemodialysis patient indicating that calcitriol may have a direct suppressive effect on bone. , 1995, Nephron.
[14] E. Bonucci,et al. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol. , 1994, Kidney international.
[15] G. Segre,et al. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. , 1994, Kidney international.
[16] H. Malluche,et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. , 1994, Kidney international.
[17] M. Burritt,et al. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3. , 1994, The Journal of clinical endocrinology and metabolism.
[18] J. Cunningham,et al. Parathyroid sensing of the direction of change of calcium in uremia. , 1993, Kidney international.
[19] F. Llach,et al. Parathyroid gland function in chronic renal failure. , 1993, Kidney international.
[20] J. Bover,et al. Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotaemic rat. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] A. Felsenfeld,et al. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease. , 1991, Journal of the American Society of Nephrology : JASN.
[22] F. Llach,et al. The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. , 1991, Journal of the American Society of Nephrology : JASN.
[23] P. Grützmacher,et al. Altered pattern of calcium kinetics in hemodialysis patients after parathyroidectomy. , 1990, ASAIO Transactions.
[24] R. Dunlay,et al. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. , 1989, Kidney international.
[25] E. Brown,et al. Hysteresis in the relationship between serum ionized calcium and intact parathyroid hormone during recovery from induced hyper- and hypocalcemia in normal humans. , 1989, The Journal of clinical endocrinology and metabolism.
[26] Keith C. Norris,et al. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. , 1989, The New England journal of medicine.
[27] E. Brown,et al. Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans. , 1988, The Journal of clinical endocrinology and metabolism.
[28] E. Bonucci,et al. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results. , 1986, Mineral and electrolyte metabolism.
[29] H. Harter,et al. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. , 1984, The Journal of clinical investigation.
[30] B. Nordin,et al. A calcium-infusion test. II. Four-hr. skeletal retention data for recognition of osteoporosis. , 1956, Lancet.